Amedisys, Inc. , together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care.
Amedisys stock last closed at $71.00, up 1.73% from the previous day, and has decreased 57.6% in one year. It has underperformed other stocks in the Medical Care Facilities industry by 0.39 percentage points. Amedisys stock is currently +2.36% from its 52-week low of $69.37, and -60.54% from its 52-week high of $179.91.
As of Mar 24, 2023, there are 32.55M shares of AMED outstanding. The market cap of AMED is $2.31B. In the last 24 hours, 251,869 AMED shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy AMED stock.
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of stock by opening an account with eToro today.
Open eToro AccountNow that you've picked your brokerage, it's time to fill out some personal information so you can invest in AMED stock today.
Now that you have finished signing up on the best stock trading app, you can securely and quickly fund your account:
Check out the video below to see the process of depositing money into your new brokerage account.
After you have selected the best place to buy Amedisys stock, it's absolutely critical to analyze their stock before you buy, so you can understand the risk as well as the opportunity.
WallStreetZen was created to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on AMED's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge AMED's true value.
Using relative valuations methods:
You can access additional valuation research on AMED's stock here.
Out of 14 Wall Street analysts who give ratings on AMED, the consensus analyst rating on Amedisys is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Bill Sutherland, a top 11% analyst from Benchmark reiterates AMED with a strong buy rating and maintains their AMED price target from $115.00 to $115.00, on Mar 14, 2023.
Scott Fidel, a top 10% analyst from Stephens & Co. reiterates AMED with a hold rating and maintains their AMED price target from $103.00 to $103.00, on Mar 14, 2023.
Steven Valiquette, a bottom 10% analyst from Barclays initiates coverage on AMED with a hold rating and announces their AMED price target of $93.00, on Mar 13, 2023.
Jonathan Yong, a bottom 9% analyst from Credit Suisse reiterates AMED with a buy rating and maintains their AMED price target from $115.00 to $115.00, on Feb 27, 2023.
Ben Hendrix, a bottom 20% analyst from RBC Capital maintains AMED with a buy rating and lowers their AMED price target from $114.00 to $111.00, on Feb 21, 2023.
You can dig deeper into what analysts are forecasting on the Amedisys stock forecast page.
Last year, AMED earnings were $118.61M. Over the past five year, AMED's earnings have grown by 32.32% per year. This was faster than the Medical Care Facilities industry average of 16.38%.
Last year, AMED revenue was $2.22B. Over the past 5 year, AMED's revenue has increased by 8.03% per year. This was slower than the Medical Care Facilities industry average of 15.66%.
Dive into AMED's earnings and revenue performance here.
In the past year, executives and large shareholders at AMED have sold more shares than they have bought.
Michael Paul North, Chief Information Officer of AMED, was the latest AMED insider to sell. They sold $510,628.44 worth of AMED stock on Mar 3, 2023.
Dig into more about who owns AMED shares here.
No, Amedisys doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main types of orders:
Press the Open button and your broker will execute the order.
If you want additional help buying stocks on eToro, click the how to video below:
Now that you own some AMED stock, you'll want to stay up-to-date on your new investment.
Make a watchlist to track your AMED stock.
To summarize, here are the 6 steps to buy Amedisys stock:
If you require a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Amedisys, get started below.